Microbot Medical Inc.MBOTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank40
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-11.02M
↓ 47% vs avg
Percentile
P40
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-7.48M
Historical baseline
PeriodValueYoY Change
TTM$-11.02M-24.5%
2024$-8.85M-3.3%
2023$-8.57M+26.4%
2022$-11.63M-23.5%
2021$-9.42M-28.3%
2020$-7.34M-10.1%
2019$-6.67M-20.5%
2018$-5.53M-12.6%
2017$-4.91M-505.9%
2016$-811000.00-